| First Author (yr) | Title | Citation | Data |
|---|
| Abecasis (2007) |
Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form. |
J Virol |
|
| Adachi (1986) |
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. |
J Virol |
|
| Adojaan (2005) |
Predominance of a rare type of HIV-1 in Estonia. |
JAIDS |
|
| Aghokeng (2007) |
Full-length sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages. |
Virology |
|
| Aghokeng (2009) |
Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries. |
Antivir Ther |
|
| Agwale (2006) |
Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients. |
ARHR |
|
| Ahuka-Mundeke (2010) |
Full-length genome sequence of a simian immunodeficiency virus (SIV) infecting a captive agile mangabey (Cercocebus agilis) is closely related to SIVrcm infecting wild red-capped mangabeys (Cercocebus torquatus) in Cameroon |
J Gen Virol |
|
| Ait-Khaled (2002) |
Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine, zidovudine in HIV-1 infected adults with no prior antiretroviral therapy. |
Antivir Ther |
|
| Ajoge (2011) |
Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in north-central Nigeria |
ARHR |
|
| Albert (1992) |
Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera. |
J Virol |
|
| Albert (1994) |
Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. |
J Virol |
|
| Albrecht (2000) |
Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine. |
ARHR |
|
| Albrecht (2001) |
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.AIDS Clinical Trials Group 364 Study Team. |
N Engl J Med |
|
| Alizon (1986) |
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. |
Cell |
|
| Anderson (2000) |
Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. |
J Virol |
|
| Andersson (1999) |
Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in west Africa. |
Virology |
|
| Andresen (2007) |
Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine. |
ARHR |
|
| Andries (2004) |
TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. |
AAC |
|
| Annaz (2011) |
Presence of drug resistance mutations among drug-naive patients in Morocco. |
ARHR |
|
| Apetrei (1998) |
Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. |
J Virol |
|
| Apetrei (2003) |
HIV type 1 diversity in northeastern Romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy. |
ARHR |
|
| Apetrei (2005) |
Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm. |
J Virol |
|
| Arien (2005) |
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. |
AIDS |
|
| Ariyoshi (2003) |
Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection. |
JAIDS |
|
| Arora (2008) |
Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India. |
ARHR |
|
| Arroyo (2004) |
HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania. |
ARHR |
|
| Arroyo (2005) |
HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. |
AIDS |
|
| Arruda (2010) |
Intermediate prevalence of HIV type 1 primary antiretroviral resistance in Ceara State, Northeast Brazil. |
ARHR |
|
| Arruda (2010) |
Genetic diversity on the integrase region of the pol gene among HIV type 1-infected patients naive for integrase inhibitors in Sao Paulo City, Brazil. |
ARHR |
|
| Atkinson (2000) |
Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine. |
J Infect Dis |
|
| Aulicino (2005) |
Sequence analysis of a south American HIV type 1 BC recombinant. |
ARHR |
|
| Aulicino (2005) |
Circulation of novel HIV type 1 A, B/C, and F subtypes in Argentina. |
ARHR |
|
| Auwanit (2009) |
Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand. |
ARHR |
|
| Avi (2009) |
Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia. |
J Med Virol |
|
| Avi (2010) |
Emerging transmitted drug resistance in treatment-naive human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia. |
Scand J Infect Dis |
|
| Avi (2010) |
Characterization of integrase region polymorphisms in HIV type 1 CRF06_cpx viruses in treatment-naive patients in Estonia. |
ARHR |
|
| Ayouba (2009) |
Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Cote d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study. |
ARHR |
|
| Azevedo-Pereira (1998) |
Complete nucleotide sequence of HIV-2ALI, a low infectious isolate with restricted tropism to primary CD4+ cells. |
Direct Genbank Submission |
|
| Azijn (2010) |
TMC278, a next-generation NNRTI, active against wild-type and NNRTI-resistant HIV-1. |
AAC |
|
| Babic (2006) |
Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004. |
Virus Res |
|
| Bacheler (2000) |
Human imunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. |
AAC |
|
| Bacheler (2001) |
Genotypic correlates of phenotypic resistance to Efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. |
J Virol |
|
| Badreddine (2007) |
Identification and characterization of hiv type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found. |
ARHR |
|
| Baier (1990) |
Complete nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence. |
Virology |
|
| Baker (2007) |
HIV subtypes distribution and implication for antiretroviral treatment in a Ugandan population. |
J Int Assoc Physicians AIDS Care (Chic) |
|
| Balakrishnan (2005) |
HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. |
ARHR |
|
| Balamane (2012) |
NNRTI patient phenotypes |
unpublished |
|
| Baldanti (2009) |
Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens. |
J Med Virol |
|
| Baldrich-Rubio (2001) |
A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa. |
J Gen Virol |
|
| Balode (2010) |
Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia. |
J Med Virol |
|
| Balotta (2000) |
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1 infected Italian patients with virologic failure. |
JAIDS |
|
| Balotta (2000) |
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region, outcome after treatment in recently infected individuals. |
Antivir Ther |
|
| Balotta (2001) |
Increasing prevalence of non-clade B HIV-1 strains heterosexuals, as monitored by the analysis of the RT and protease sequences. |
JAIDS |
|
| Balzarini (1998) |
A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781. |
ARHR |
|
| Bang (2008) |
Prevalence of primary antiretroviral resistance: trends in Korea. |
ARHR |
|
| Barditch-Crovo (2001) |
Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. |
AAC |
|
| Barlow (2003) |
Characterization of a novel simian immunodeficiency virus(SIVmonNG1) genome sequence from a mona monkey(cercopithecus mona). |
J Virol |
|
| Barnett (1993) |
Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain. |
J Virol |
|
| Barnett (1996) |
Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2-UC2. |
Virology |
|
| Barreto (2006) |
Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil. |
JAIDS |
|
| Bartolo (2009) |
HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique. |
JAIDS |
|
| Bartolo (2009) |
Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance. |
AAC |
|
| Bartolo (2010) |
Origin and epidemiological history of CRF14_BG |
unpublished |
|
| Baxter (2000) |
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 study team for the Terry Beirn community programs for Clinical research on AIDS. |
AIDS |
|
| Baxter (2006) |
Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir. |
J Virol |
|
| Becker (1995) |
Molecular and phylogenetic characterisation of a Guineau-Bissau-derived human immunodeficiency virus type 2 isolate. |
Direct Genbank Submission |
|
| Becker-Pergola (2000) |
Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug naive Ugandan adults. |
ARHR |
|
| Beer (1999) |
Simian immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C.lhoesti superspecies. |
J Virol |
|
| Beer (2000) |
Patterns of genomic sequence diversity among their simian immunodeficiency viruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir. |
J Virol |
|
| Beer (2001) |
Characterization of novel simian immunodeficiency viruses from red-capped mangabeys from Nigera. |
J Virol |
|
| Belec (2000) |
High levels of drug resistance human immuno deficiency virus variants in patients exhibiting increasing CD4 + t cell counts despite virologic failure of protease inhibitors containing antiretroviral combination therapy. |
J Infect Dis |
|
| Bellocchi (2005) |
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme. |
J Med Virol |
|
| Bellosillo (2003) |
G190A substitution is associated with delavirdine(DLV) hypersusceptibility in vitro and clinical response with DLV intensification. |
Antivir Ther |
|
| Benn (1985) |
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. |
Science |
|
| Benveniste (1988) |
Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. |
J Virol |
|
| Bernardin (2005) |
HIV-1 Isolates from Canada, primary infection. |
Direct Genbank Submission |
|
| Bernardin (2005) |
Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes. |
J Virol |
|
| Bessong (2005) |
Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence. |
ARHR |
|
| Bessong (2006) |
Resistance mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals. |
ARHR |
|
| Bibollet-Ruche (2004) |
Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2). |
ARHR |
|
| Bibollet-Ruche (2004) |
New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade. |
J Virol |
|
| Blanco (2011) |
HIV-1 integrase inhibitor resistance: new developments and their clinical implications. |
J Infect Dis |
|
| Bodelle (2004) |
Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon. |
ARHR |
|
| Bonhoeffer (2004) |
Evidence for positive epistasis in HIV-1. |
Science |
|
| Bontell (2011) |
Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam |
Infect Genet Evol |
|
| Bonura (2010) |
Transmission of drug-resistant HIV type 1 strains in HAART-naive patients: a 5-year retrospective study in Sicily, Italy. |
ARHR |
|
| Bouchard (2007) |
HIV type 1 drug resistance among naive patients from Venezuela. |
ARHR |
|
| Bouzeghoub (2006) |
High diversity of HIV type 1 in Algeria. |
ARHR |
|
| Bradshaw (2007) |
Characterization of a novel drug-resistance pattern associated with the mutations K70G and M184V in HIV-1 reverse transcriptase. |
AAC |
|
| Brandin (2003) |
Pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy. |
ARHR |
|
| BrÃgido (2011) |
Southern Brazil HIV type 1 C expansion into the state of São Paulo, Brazil |
ARHR |
|
| Brehm (2011) |
Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase |
JAIDS |
|
| Brennan (2000) |
Genetic variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma. |
ARHR |
|
| Brennan (2007) |
HIV-1 strains identified in Brazilian blood donors: significant prevalence of B/F1 recombinants. |
ARHR |
|
| Brennan (2008) |
The prevalence of diverse hiv-1 strains was stable in cameroonian blood donors from 1996 to 2004. |
JAIDS |
|
| Brennan (2009) |
Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors. |
Transfusion |
|
| Brennan (2010) |
Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007 |
Transfusion |
|
| Brigido (2007) |
HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil. |
ARHR |
|
| Brindeiro (2002) |
Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy. |
J Clin Microbiol |
|
| Brindeiro (1999) |
Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals. |
AAC |
|
| Brindeiro (2003) |
Brazilian network for HIV drug resistance surveillance (HIV-BResNet): a survey of chronically infected individuals. |
AIDS |
|
| Brown (2000) |
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites. |
J Virol |
|
| Brown (2005) |
Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. |
J Virol |
|
| Brumme (2007) |
Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. |
PLoS Pathog |
|
| Brumme (2009) |
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. |
PLoS Med |
|
| Brun (2001) |
Patterns of protease inhibitor cross resistance in viral isolates with reduced susceptibility to lopinavir. |
CROI 2001 |
|
| Bunupuradah (2011) |
Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens |
Antivir Ther |
|
| Burda (2010) |
HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naive to HAART in Cameroon. |
J Med Virol |
|
| Burns (2002) |
Sequence variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes. |
ARHR |
|
| Bussmann (2005) |
HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. |
Antivir Chem Chemother |
|
| Buzon (2008) |
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy. |
Antivir Ther |
|
| Byrnes (1993) |
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors. |
AAC |
|
| Byrnes (1994) |
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. |
AAC |
|
| Cabana (1999) |
Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors. |
J Med Virol |
|
| Camacho (2005) |
Patients infected with Non-B isolates from Portugal. |
PLoS Med |
|
| Canducci (2009) |
Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies. |
AIDS |
|
| Cardoso (2009) |
HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from Central West Brazil. |
J Clin Virol |
|
| Cardoso (2009) |
High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil. |
ARHR |
|
| Caride (2001) |
Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. |
Virus Genes |
|
| Caron (2008) |
Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa. |
ARHR |
|
| Carr (1996) |
Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. |
J Virol |
|
| Carr (1998) |
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. |
Virology |
|
| Carr (1999) |
Direct Genbank submission: HIV-1 isolates from the Democratic Republic of the Congo and from Gabon. |
Direct Genbank Submission |
|
| Carr (1999) |
Characterization of subtype A HIV-1 from Africa by full genome sequencing. |
AIDS |
|
| Carr (2001) |
The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. |
Virology |
|
| Carr (2001) |
Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. |
AIDS |
|
| Carr (2005) |
HIV subtype and drug resistance patterns among drug-naive infected persons in Jos, Nigeria. |
Direct Genbank Submission |
|
| Carr (2005) |
Outbreak of West African recombinant of HIV-1 in Tashkent, Uzbekistan. |
JAIDS |
|
| Carr (2006) |
High genetic complexity of HIV-1 in low-prevalence, rural regions of Cameroon. |
Direct Genbank Submission |
|
| Carr (2008) |
Identification of CRF17_BF in four South American countries. |
Direct Genbank Submission |
|
| Carr (2010) |
HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: evolutionary relics? |
Retrovirology |
|
| Carrillo (1998) |
In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378. |
J Virol |
|
| Carrion (2003) |
Circulating recombinant form CRF02_AG in south America. |
ARHR |
|
| Carrion (2004) |
Documentation of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay. |
ARHR |
|
| Carvalho (2011) |
Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland north state of Tocantins, Brazil. |
ARHR |
|
| Casado (2003) |
Near full-length genome characterization of an HIV type 1 CRF05_DF virus from Spain. |
ARHR |
|
| Casado (2005) |
Identification of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba. |
JAIDS |
|
| Castelbranco (2010) |
Frequency of primary resistance to antiretroviral drugs and genetic variability of HIV-1 among infected pregnant women recently diagnosed in Luanda-Angola. |
ARHR |
|
| Castillo (2009) |
Surveillance of HIV type 1 drug resistance among naive patients from Venezuela. |
ARHR |
|
| Caumont (2001) |
Sequence analysis of env C2/V3, gag p17/p24, and pol protease regions of 25 HIV type 1 Isolates from Ho Chi Minh city, Vietnam. |
ARHR |
|
| Chaix (2003) |
Stable prevalence of genotypic drug resistance mutatioins but increase in non-B virus among patients with primary HIV-1 infection in France. |
AIDS |
|
| Chakrabarti (1987) |
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. |
Nature |
|
| Chamberland (2011) |
HIV-1 primary drug resistance prevalence in Cotonou, Benin. |
Direct Genbank Submission |
|
| Chang (2008) |
Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. |
J Antimicrob Chemother |
|
| Charpentier (2008) |
Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy. |
HIV Med |
|
| Charpentier (2011) |
High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger. |
Antivir Ther |
|
| Chaturbhuj (2010) |
Transmitted HIV drug resistance among HIV-infected voluntary counseling and testing centers (VCTC) clients in Mumbai, India. |
ARHR |
|
| Chen (1996) |
Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop. |
J Virol |
|
| Chibo (2011) |
HIV transmissions during seroconversion contribute significantly to new Infections in men who have sex with men in Australia |
ARHR |
|
| Chin (2006) |
Inverse relationship between viral load and genotypic resistance mutations in Korean patients with primary HIV type 1 infections. |
ARHR |
|
| Chin (2010) |
Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China. |
ARHR |
|
| Cho (2002) |
Frequency of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea. |
J Clin Microbiol |
|
| Choi (1997) |
HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant. |
ARHR |
|
| Church (2007) |
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D. |
ARHR |
|
| Church (2008) |
Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. |
J Infect Dis |
|
| Ciccozzi (2005) |
Molecular diversity of HIV in Albania. |
J Infect Dis |
|
| Cinque (2001) |
Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. |
ARHR |
|
| Clavel (1986) |
Isolation of a new human retrovirus from West African patients with AIDS. |
Science |
|
| Clevenbergh (2002) |
Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1. |
Antivir Ther |
|
| Clewley (1998) |
A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus. |
J Virol |
|
| Coakley (2005) |
Atazanavir resistance in a protease inhibitor-naive patient treated with atazanavir/ritonavir associated with development of high-level atazanavir resistance and the N88S mutation in protease. |
CROI 2007 |
|
| Coakley (2000) |
Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine. |
AIDS |
|
| Collman (1992) |
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. |
J Virol |
|
| Colonno (2004) |
Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens. |
J Infect Dis |
|
| Condra (1995) |
In vivo emergence of HIV-1 variants resistant to multiple proteaseinhibitors. |
Nature |
|
| Condra (1996) |
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. |
J Virol |
|
| Corbet (2000) |
Env sequences of SIV from chimpanzees in Cameroon are strongly related to HIV group N from the same geographic area. |
J Virol |
|
| Cornelissen (1997) |
pol diversity of five HIV-1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. |
J Virol |
|
| Cornelissen (2000) |
Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. |
J Gen Virol |
|
| Courgnaud (1992) |
Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque. |
J Virol |
|
| Courgnaud (2001) |
Characterization of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family. |
J Virol |
|
| Courgnaud (2002) |
Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. |
J Virol |
|
| Courgnaud (2003) |
Partial molecular characterization of two simian immunodeficiency viruses (SIV) from African colobids: SIVwrc from western red colobus (Piliocolobus badius) and SIVolc from olive colobus (Procolobus verus). |
J Virol |
|
| Courgnaud (2003) |
Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon. |
J Virol |
|
| Couto-Fernandez (2006) |
Phylogenetic analysis of Brazilian HIV type 1 subtype D strains: tracing the origin of this subtype in Brazil. |
ARHR |
|
| Craig (1998) |
HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy. |
AIDS |
|
| Cuevas (2009) |
Incidence of non-B subtypes of HIV-1 in Galicia, Spain: high frequency and diversity of HIV-1 among men who have sex with men. |
Euro Surveill |
|
| Cuevas (2002) |
High HIV-1 genetic diversity in Cuba. |
AIDS |
|
| Cuevas (2009) |
HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain. |
JAIDS |
|
| Cuevas (2010) |
Short communication: Biological and genetic characterization of HIV type 1 subtype B and nonsubtype B transmitted viruses: usefulness for vaccine candidate assessment. |
ARHR |
|
| da Silva (2010) |
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens. |
J Antimicrob Chemother |
|
| Dalai (2009) |
Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe. |
AIDS |
|
| Damond (2004) |
Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. |
ARHR |
|
| Das (2004) |
Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. |
J Med Chem |
|
| Das (2008) |
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations. |
PNAS |
|
| Dauber (2002) |
Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease. |
J Virol |
|
| Dazza (2005) |
Characterization of a novel vpu-harboring simian immunodeficiency virus from a Dent's mona monkey (Cercopithecus mona denti). |
J Virol |
|
| de Baar (2000) |
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. |
ARHR |
|
| de Medeiros (2011) |
Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: Analysis of primary resistance mutations |
J Med Virol |
|
| De Meyer (2008) |
Characterization of virologic failures on darunavir/ritonavir in the randomized, controlled, Phase III TITAN trial in treatment-experienced patients. |
CROI 2008 |
|
| de Sa Filho (2002) |
Mutations associated with drug resistance in a population of drug naive HIV-1 infected individuals. |
Direct Genbank Submission |
|
| de Sa Filho (2003) |
Analysis of the protease sequences of HIV-1 infected individuals after indinavir monotherapy. |
J Clin Virol |
|
| de Sa Filho (2005) |
Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil. |
ARHR |
|
| de Sa Filho (2006) |
Identification of two HIV type 1 circulating recombinant forms in Brazil. |
ARHR |
|
| de Sa Filho (2008) |
HIV type 1 poltype 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil. |
ARHR |
|
| de Sa-Filho (2009) |
HIV type 1 diversity from newly diagnosed patients in Santos metropolitan area/Brazil. |
ARHR |
|
| de Silva (2011) |
HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form. |
ARHR |
|
| Deeks (1999) |
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome. |
J Infect Dis |
|
| Deho (2008) |
Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland. |
ARHR |
|
| Delaugerre (2005) |
Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF. |
J Clin Virol |
|
| Delaunay (2005) |
Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021). |
J Virol |
|
| Delelis (2009) |
Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo. |
AAC |
|
| Delgado (2001) |
Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study. |
ARHR |
|
| Delgado (2002) |
Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. |
JAIDS |
|
| Delgado (2008) |
High prevalence of unique recombinant forms of HIV-1 in Ghana: molecular epidemiology from an antiretroviral resistance study. |
JAIDS |
|
| Delgado (2010) |
Identification of a new HIV type 1 BF intersubtype circulating recombinant form (CRF44_BF) in Chile. |
ARHR |
|
| Delgado (2004) |
Genotypic (and phenotypic) predictors of a response to DDI monotherapy in ZDV-experienced patients. |
Antivir Ther |
|
| Demeter (2000) |
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type I isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). |
AAC |
|
| Derache (2007) |
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali. |
Antivir Ther |
|
| Derache (2008) |
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006. |
J Antimicrob Chemother |
|
| Descamps (1997) |
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. |
J Virol |
|
| Deshpande (2004) |
Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations. |
ARHR |
|
| Deshpande (2009) |
Phylogenetic analysis of HIV-1 reverse transcriptase sequences from 382 patients recruited in JJ Hospital of Mumbai, India, between 2002 and 2008 |
ARHR |
|
| Deshpande (2010) |
Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines. |
ARHR |
|
| Deshpande (2011) |
Drug Resistance Mutations in HIV Type 1 Isolates from Naive Patients Eligible for First Line Antiretroviral Therapy in JJ Hospital, Mumbai, India |
ARHR |
|
| Dewhurst (1990) |
Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 |
Nature |
|
| Dietrich (1989) |
A highly divergent HIV-2-related isolate. |
Nature |
|
| Dilernia (2007) |
HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina. |
ARHR |
|
| Diop-Ndiaye (2010) |
Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal. |
ARHR |
|
| Djoko (2010) |
HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea. |
ARHR |
|
| Djoko (2010) |
High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, DRC. |
ARHR |
|
| Doualla-Bell (2006) |
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. |
AAC |
|
| Doualla-Bell (2006) |
Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen |
AAC |
|
| Dowling (2002) |
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. |
AIDS |
|
| Doyon (2005) |
Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir. |
Antiviral Res |
|
| Dueweke (1993) |
A mutation in reverse transcriptase of bis(heteroaryl)piperazine- resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors. |
PNAS |
|
| Dumans (2002) |
Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil. |
AAC |
|
| Dumans (2004) |
Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance. |
J Infect Dis |
|
| Dumans (2009) |
Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure. |
Infect Genet Evol |
|
| Dunne (2001) |
Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs. |
AIDS |
|
| Duque (2002) |
Direct Genbank submission: Prevalence of drug resistance and HIV-1 subtypes in antiretroviral inexperienced patients, during the year 2000 in Portugal. |
Direct Genbank Submission |
|
| Duque (2003) |
Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal. |
Clin Microbiol Infect |
|
| Dykes (2001) |
Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants. |
Virology |
|
| El-Khatib (2010) |
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa |
AIDS |
|
| Ellenberger (1999) |
Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G. |
ARHR |
|
| Ellrodt (1984) |
Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes. |
Lancet |
|
| Emini (1993) |
HIV and multidrug resistance. |
Nature |
|
| Escoto-Delgadillo (2005) |
Drug-resistance mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico. |
HIV Med |
|
| Eshleman (2001) |
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (HIV network for prevention trials 012 study). |
J Infect Dis |
|
| Eshleman (2001) |
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377). |
J Infect Dis |
|
| Eshleman (2002) |
Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D. |
ARHR |
|
| Eshleman (2002) |
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012). |
JAIDS |
|
| Eshleman (2004) |
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012. |
ARHR |
|
| Eshleman (2004) |
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine. |
JAIDS |
|
| Eshleman (2004) |
Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. |
J Clin Microbiol |
|
| Eshleman (2005) |
Limited evolution in the HIV type 1 pol region among acute seroconverters in Pune, India. |
ARHR |
|
| Eshleman (2005) |
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. |
J Infect Dis |
|
| Eshleman (2006) |
Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations. |
ARHR |
|
| Eshleman (2007) |
Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. |
AIDS |
|
| Eshleman (2009) |
Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay. |
ARHR |
|
| Eshleman (2009) |
Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda. |
AIDS |
|
| Espinosa (2004) |
Intersubtype BF recombinants of HIV-1 in a population of injecting drug users in Argentina. |
JAIDS |
|
| Etienne (2011) |
Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms |
Retrovirology |
|
| Evans (1988) |
Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression. |
Science |
|
| Eyer-Silva (2007) |
Autochthonous horizontal transmission of a CRF02_AG strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of Rio de Janeiro, Southeast Brazil. |
Mem Ins Oswaldo Cruz |
|
| Eyzaguirre (2007) |
Genetic characterization of hiv-1 strains circulating in Kazakhstan. |
JAIDS |
|
| Falloon (2000) |
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity. |
Clin Infect Dis |
|
| Fang (2004) |
Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations. |
J Infect Dis |
|
| Fernandez-Garcia (2010) |
Identification of a new HIV type 1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain. |
ARHR |
|
| Fernandez-Garcia (2009) |
Near full-length genome characterization of a newly identified HIV type 1 subtype F variant circulating in St. Petersburg, Russia. |
ARHR |
|
| Ferreira (2011) |
Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil. |
J Med Virol |
|
| Ferreira (2010) |
Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically Infected children in Belo Horizonte, Brazil. |
ARHR |
|
| Ferreira (2008) |
Molecular characterisation of newly identified HIV-1 infections in Curitiba, Brazil: preponderance of clade C among males with recent infections. |
Mem Ins Oswaldo Cruz |
|
| Fish (2010) |
Natural polymorphisms of integrase among HIV type 1-infected South African patients. |
ARHR |
|
| Fitzgibbon (1992) |
Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine. |
AAC |
|
| Fitzgibbon (1993) |
Human immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugs. |
J Virol |
|
| Fitzgibbon (2001) |
Emergence of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimens. |
ARHR |
|
| Flores (1999) |
HIV-1 subtype F in single and dual infections in Puerto Rico: a potential sentinel site for monitoring novel genetic HIV variants in north America. |
Emerg Infect Dis |
|
| Foli (1996) |
In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-{2-(phosphonomethoxy)ethyl}adenine (PMEA). |
Antiviral Res |
|
| Fomsgaard (1991) |
A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey. |
Virology |
|
| Fonjungo (2002) |
Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features. |
J Clin Microbiol |
|
| Franchini (1989) |
Molecular and biological characteristics of a replication competent human immunodeficiency virus type 2 (HIV-2) proviral clone. |
PNAS |
|
| Fransen (2009) |
HIV-1 mutations at positions 143, 148, and 155 of integrase define different genetic barriers to raltegravir resistance in vivo. |
CROI 2009 |
|
| Fransen (2009) |
Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways. |
J Virol |
|
| Friend (2004) |
Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen. |
AIDS |
|
| Fujisaki (2009) |
An 11-Year Surveillance of HIV Type 1 Subtypes in Nagoya, Japan. |
ARHR |
|
| Fujiwara (1998) |
S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1. |
AAC |
|
| Fukasawa (1988) |
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. |
Nature |
|
| Galkin (2006) |
Sequencing and analysis of full-length HIV-1 CRF06_cpx isolate from Russia. |
Direct Genbank Submission |
|
| Galkin (2006) |
Full-length genomic sequencing and analysis of four HIV type 1 subtype B isolates circulating in the territory of Russia. |
ARHR |
|
| Gallant (2005) |
Early virologic non-response to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral naive subjects. |
J Infect Dis |
|
| Galluzzo (2007) |
Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda. |
ARHR |
|
| Gao (1992) |
Human infection by genetically diverse SIVSM-related HIV-2 in West Africa. |
Nature |
|
| Gao (1994) |
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. |
J Virol |
|
| Gao (1996) |
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. |
J Virol |
|
| Gao (1996) |
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID networks for HIV isolation and characterization. |
J Virol |
|
| Gao (1998) |
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. |
J Virol |
|
| Gao (1998) |
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes. |
J Virol |
|
| Gao (1999) |
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. |
Nature |
|
| Gao (2001) |
Molecular characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo. |
ARHR |
|
| Gao (2001) |
Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. |
ARHR |
|
| Gao (2003) |
Complete genomes of HIV-1 subtype C viruses in South Africa. |
Direct Genbank Submission |
|
| Gao (2005) |
Recombination in human immunodefeciency virus type 2. |
Direct Genbank Submission |
|
| Garcia-Bujalance (2005) |
Comparison between sequence analysis and a line probe assay for testing genotypic resistance of human immunodeficiency virus type 1 to antiretroviral drugs. |
J Clin Microbiol |
|
| Garrido (2009) |
Dynamics in the selection of resistance mutations in HIV patients failing raltegravir and following its discountinuation. |
EUHIV DRW 2009 |
|
| Garrido (2009) |
Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection. |
J Antimicrob Chemother |
|
| Gatanaga (1999) |
Anti-HIV effect of saquinavir combined with ritonavir is limited by previous long-term therapy with protease inhibitors. |
ARHR |
|
| Gatanaga (2007) |
Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan. |
Antiviral Res |
|
| Gibb (2002) |
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial). |
Antivir Ther |
|
| Gittens (2003) |
The molecular epidemiology and drug resistance determination of HIV type 1 subtype B infection in Barbados. |
ARHR |
|
| Gody (2008) |
High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised who recommendations. |
JAIDS |
|
| Goethals (2008) |
Resistance mutations in HIV-1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors. |
J Virol |
|
| Goethals (2010) |
Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles. |
Virology |
|
| Gomez-Carrillo (2004) |
Drug resistance testing provides evidence of the globalization of HIV type 1: a new circulating recombinant form. |
ARHR |
|
| Gong (2000) |
In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632. |
AAC |
|
| Gonsalez (2007) |
Drug resistance among chronic HIV-1-infected patients naive for use of anti-retroviral therapy in Sao Paulo city. |
Virus Res |
|
| Gonzales (2001) |
HIV-1 reverse transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a Northern California clinic-based population. |
J Infect Dis |
|
| Gonzales (2003) |
Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors. |
AIDS |
|
| Gonzales (2003) |
Protease and reverse transcriptase mutation patterns in HIV-1 isolates from heavily treated persons: comparison of isolates from northern California with isolates from other regions. |
ARHR |
|
| Gonzales (2003) |
Colinearity of reverse transcriptase inhibitor resistance mutations detected by population-based sequencing. |
JAIDS |
|
| Gonzalez (2003) |
Epidemiological and molecular characteristcs of HIV and HTLV infection in Equatorial Guinea, 1996-1998. |
Direct Genbank Submission |
|
| Gonzalez (2010) |
Short communication: antiretroviral therapy resistance mutations present in the HIV type 1 subtype C pol and env regions from therapy-naive patients in Zambia. |
ARHR |
|
| Goodman (2008) |
Integrase inhibitor resistance involves complex interactions among primary and secondary resistance mutations: a novel mutation L68V/I associates with E92Q and increases resistance. |
IHDRW 2008 |
|
| Gordon (2003) |
Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies. |
J Virol |
|
| Graf (1998) |
Cloning and characterization of a virtually full-length HIV-1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in china. |
ARHR |
|
| Graf (2011) |
HIV-1 genetic diversity and drug resistance among treatment naïve patients from Southern Brazil: an association of HIV-1 subtypes with exposure categories. |
J Clin Virol |
|
| Grossman (2004) |
Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. |
AAC |
|
| Grossman (2005) |
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration. |
PLoS Med |
|
| Grossman (2005) |
Drug-resistant HIV infection among drug-naive patients in Israel. |
Clin Infect Dis |
|
| Guimaraes (2009) |
Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates. |
Retrovirology |
|
| Gulick (2004) |
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. |
N Engl J Med |
|
| Guo (2009) |
First detection of a novel HIV Type 1 CRF01_AE/07_BC recombinant among an epidemiologically linked cohort of IDUs in Jiangsu, China. |
ARHR |
|
| Gurgo (1988) |
Envelope sequences of two new United States HIV-1 isolates. |
Virology |
|
| Gurtler (1994) |
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. |
J Virol |
|
| Hai-Long (2007) |
Genetic characterization of CRF01_AE full-length human immunodeficiency virus type 1 sequences from Fujian, China. |
ARHR |
|
| Hall (2006) |
Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir. |
J Virol |
|
| Hamers (2010) |
HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia. |
JAIDS |
|
| Hamkar (2010) |
Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients. |
AIDS |
|
| Hammer (1997) |
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. |
N Engl J Med |
|
| Han (2007) |
Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference. |
ARHR |
|
| Handema (2002) |
Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1. |
ARHR |
|
| Hanna (2003) |
Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection. |
J Infect Dis |
|
| Harrigan (1996) |
Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility. |
J Virol |
|
| Harrigan (2002) |
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance. |
J Virol |
|
| Harrigan (2005) |
Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors. |
AIDS |
|
| Harris (2005) |
Genomic characterization of a novel HIV type 1 B/G intersubtype recombinant strain from an injecting drug user in Germany. |
ARHR |
|
| Harris (2002) |
Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate. |
ARHR |
|
| Harris (2003) |
A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions. |
ARHR |
|
| Hasegawa (1989) |
Genomic divergence of HIV-2 from Ghana. |
ARHR |
|
| Hatano (2010) |
Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy. |
Journal of Acquired |
|
| Hawkins (2009) |
Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria. |
JAIDS |
|
| Hazuda (2004) |
A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. |
PNAS |
|
| Heredia (1997) |
Evidence of HIV-2 infection in Equatorial Guinea (Central Africa): partial genetic analysis of a B subtype virus. |
ARHR |
|
| Heredia (1997) |
Genetic analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS. |
ARHR |
|
| Herring (2001) |
Natural variation in HIV-1 integrase in Australia. |
Direct Genbank Submission |
|
| Herring (2004) |
Potential drug resistance polymorphisms in the integrase gene of HIV type 1 subtype A. |
ARHR |
|
| Hertogs (2000) |
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V. |
AAC |
|
| Hierholzer (2002) |
Molecular epidemiology of HIV type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina. |
ARHR |
|
| Hierholzer (2002) |
HIV type 1 strains from east and west Africa are intermixed in Sudan. |
ARHR |
|
| Hirsch (1987) |
The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein. |
Cell |
|
| Hirsch (1989) |
An African primate lentivirus (SIVsm) closely related to HIV-2. |
Nature |
|
| Hirsch (1993) |
A distinct African lentivirus from Sykes' monkeys. |
J Virol |
|
| Hirsch (1995) |
Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. |
J Virol |
|
| Hirsch (1997) |
A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. |
J Virol |
|
| Hirsch (1999) |
Characterization of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): implications for the origins of SIVmnd and other primate lentiviruses. |
J Virol |
|
| Ho (1994) |
Characterization of human immunodeficiency virus type1 variants with increased resistance to a C2-symmetric protease inhibitor. |
J Virol |
|
| Hoelscher (2001) |
High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania. |
AIDS |
|
| Hoffmann (2009) |
Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First-Line Antiretroviral Therapy in South Africa |
Clin Infect Dis |
|
| Holguin (2000) |
Recombinant human immunodeficiency viruses type 1 circulating in Spain. |
ARHR |
|
| Holguin (2000) |
Protease gene analysis of HIV Type 1 non-B subtypes in Spain. |
ARHR |
|
| Holguin (2001) |
Prevalence of human immunodeficiency virus type 1 (HIV-1) Non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5. |
J Clin Microbiol |
|
| Holguin (2002) |
High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid. |
AIDS |
|
| Holguin (2002) |
HIV-1 subtype J recombinant viruses in Spain. |
ARHR |
|
| Holguin (2003) |
HIV-positive immigrants in the Canary Islands, Spain: implications for public health in Europe. |
HIV Clin Trials |
|
| Holguin (2004) |
Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes. |
J Clin Virol |
|
| Holguin (2005) |
Heterogeneous nature of HIV-1 recombinants spreading in Spain. |
J Med Virol |
|
| Holguin (2005) |
Differences in the length of gag proteins among different HIV type 1 subtypes. |
ARHR |
|
| Holguin (2007) |
Introduction of non-B subtypes among Spaniards newly diagnosed with HIV type 1 in the Canary Islands. |
ARHR |
|
| Holguin (2008) |
Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools. |
J Med Virol |
|
| Holzmayer (2005) |
Near-full-length genomic sequence of a human immunodeficiency type 1 subtype g strain from cameroon. |
ARHR |
|
| Holzmayer (2009) |
Characterization of genetically diverse HIV type 1 from a London cohort: near full-length genomic analysis of a subtype H strain. |
ARHR |
|
| Hombrouck (2008) |
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137. |
AAC |
|
| Hosseinipour (2009) |
The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. |
AIDS |
|
| Howard (1996) |
Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria. |
ARHR |
|
| Hsu (2005) |
Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment naive and experienced patients in Singapore. |
JAIDS |
|
| Hu (2003) |
Characterization and comparison of recombinant simian immunodeficiency virus from drill (Mandrillus leucophaeus) and mandrill (Mandrillus sphinx) isolates. |
J Virol |
|
| Hu (2007) |
Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase |
JAIDS |
|
| Huang (2003) |
Sequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel. |
ARHR |
|
| Huang (2009) |
Complex mosaic composition of near full-length genomes of two NED (NIH-ENVA-DOD) subtype panel HIV type 1 strains, BCF-Dioum and BCF-Kita, originating from the Democratic Republic of Congo (DRC). |
ARHR |
|
| Huang (2006) |
Genetic characterization of three CRF01_AE full-length HIV type 1 sequences from Fujian province, China. |
Chin Med J (Engl) |
|
| Huang (1999) |
Complex interactions involving multiple amino acid substitutions alter NNRTI susceptibility. |
Antivir Ther |
|
| Huang (2000) |
A novel HIV-1 RT mutation (M230L) confers NNRTI resistance and dose-dependent stimulation of replication. |
Antivir Ther |
|
| Huang (2003) |
Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication. |
J Virol |
|
| Huet (1989) |
A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot. |
AIDS |
|
| Huet (1990) |
Genetic organization of a chimpanzee lentivirus related to HIV-1. |
Nature |
|
| Hunt (2003) |
Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates. |
Virus Genes |
|
